The Conference on Retroviruses and Opportunistic Infections (CROI), an annual preeminent HIV research meeting, was held in Seattle, Washington, February 13-16 this year. CROI gathers scientists researching epidemiology and biology of human retroviruses and associated diseases to discuss their findings.
This blog post is a collection of HIV/HCV highlights that were presented. Please scroll down and click on the subjects that interest you.
Interesting Meeting Abstracts about HIV/HCV Coinfection
- Hepatocellular Carcinoma after SVR with IFN-Free Regimens in HIV/HCV Coinfection (Abstract Number 139) by Nicolas Merchante, et al.
- Identification of HCV Inter-Subtype Recombinant Strains with Breakpoints in NS5A (Abstract Number 140) by Suqin Cal, et al.
- Hepatitis C Virus Genotype and IG-G Avidity Response During Recent Infection (Abstract Number 516) by Veronica Bruce, et al.
- Effect of OST and Psychotherapy on HIV Risk Among HCV Infected Individuals (Abstract Number 524) by Zahid A. Butt, et al.
- The Association Between HCV and Comorbid Conditions in 2 Large Patient Cohorts (Abstract Number 528) by Sarah E. Rowan, et al.
- Cause & Predictors of Mortality in an HIV/Hepatitis-C-Coinfected Cohort in Scotland (Abstract Number 529) by Rebecca Metcalfe, et al.
More information about The Conference on Retroviruses and Opportunistic Infections (CROI), or these and other studies can be found in our blog post CROI 2017 Hep C Highlights Part II or on the conference’s website.